Medicalgorithmics integrates two further clients. Samsung spin-off among them
Medicalgorithmics, a Polish medtech company listed on the Warsaw Stock Exchange, has completed the integration of its ECG analysis software (DRP) using proprietary AI algorithms (DRAI) with two major technology partners. One of them is the leading Korean distributor Wellysis, a Samsung spinoff specializing in projects in the field of ECG monitoring, predictive analytics, and artificial intelligence models in healthcare. The innovative platform and AI algorithms have been integrated into Wellysis’ flagship S-Patch device (approved by the FDA in the US) and will be available to all current and future customers of both companies, including in the US. The second implementation concerns a Canadian deep-tech company with which the Company established cooperation in August this year. Medicalgorithmics has already integrated eight customers from partnerships established this year.